---
document_datetime: 2024-09-25 10:21:39
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/zoonotic-influenza-vaccine-seqirus-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: zoonotic-influenza-vaccine-seqirus-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 1.520295
conversion_datetime: 2025-12-25 12:50:46.909467
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
<!-- image -->

## Zoonotic Influenza Vaccine Seqirus

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                               | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0004              | B.II.f.1.b.5 - Stability of FP - Extension of the shelf life of the finished product - Biological/immunological medicinal product in accordance with an approved stability protocol | 24/09/2024                          |                                             | SmPC                             |           |
| IB/0005/G            | This was an application for a group of variations.                                                                                                                                  | 28/08/2024                          | n/a                                         |                                  |           |

Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                     | B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation A.7 - Administrative change - Deletion of manufacturing sites A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient   |            |            |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10008 /202310 | Periodic Safety Update EU Single assessment - pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted), prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)                                                                                                                                                                                                                       | 16/05/2024 | n/a        |                        | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                         |
| II/0001             | B.I.a.5.a - Changes to the AS of a seasonal, prepandemic or pandemic vaccine against human influenza - Replacement of the strain(s) in a seasonal, prepandemic or a pandemic vaccine against human influenza                                                                                                                                                                                                                      | 21/03/2024 | 09/04/2024 | SmPC, Labelling and PL | For more information, please refer to the Summary of Product Characteristics. The SmPC sections 1, 2, 3, 4.1,4.2, 4.3, 4.4, 4.5, 4.6, 4.8, 5.1, 5.3, 6.3 and 6.6, have been updated as follows: To include the updated vaccine strain: A/Astrakhan/3212/2020 (H5N8)-like strain (CBER-RG8A) (clade 2.3.4.4b) and to rationalise the text in relation to the updated H5N8 strain. Annex A, Labelling and PL have been updated accordingly. |